These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7201547)

  • 1. Quantitative changes in estrogen receptor produced by chronic DES treatment of two mouse strains differing in susceptibility to Leydig cell tumor induction.
    Terakawa N; Huseby RA; Fang SM; Samuels LT
    J Steroid Biochem; 1982 May; 16(5):643-52. PubMed ID: 7201547
    [No Abstract]   [Full Text] [Related]  

  • 2. Increase in testis luteinizing hormone receptor by estrogen in mice susceptible to Leydig cell tumors.
    Navickis RJ; Shimkin MB; Hsueh AJ
    Cancer Res; 1981 May; 41(5):1646-51. PubMed ID: 6260347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The testicular estrogen receptor system in two strains of mice differing in susceptibility to estrogen-induced Leydig cell tumors.
    Sato B; Spomer W; Huseby RA; Samuels LT
    Endocrinology; 1979 Mar; 104(3):822-31. PubMed ID: 436739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
    Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
    Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen binding component of mouse Leydig cell tumor: an in vitro conversion from nonreceptor to receptor-like molecule.
    Sato B; Maeda Y; Noma K; Matsumoto K; Yamamura Y
    Endocrinology; 1981 Feb; 108(2):612-9. PubMed ID: 7449741
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma testosterone concentrations in normal and estrogen treated mice of three strains differing in susceptibility to induction of Leydig cell tumors.
    McCormack SA; Huseby RA
    J Steroid Biochem; 1979 Oct; 11(4):1407-11. PubMed ID: 41978
    [No Abstract]   [Full Text] [Related]  

  • 7. DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes.
    Spruance SL; Wilcox B; Richards OC; Foster DN; Huseby RA; Samuels LT
    Cancer Res; 1978 Feb; 38(2):424-30. PubMed ID: 620411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular tumors in mice exposed in utero to diethylstilbestrol.
    Newbold RR; Bullock BC; McLachlan JA
    J Urol; 1987 Dec; 138(6):1446-50. PubMed ID: 3682076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tamoxifen on estrogen-induced enhancement or inhibition of tumor growth in mouse Leydig cell tumor lines.
    Sato B; Maeda Y; Nishizawa Y; Noma K; Kishimoto S; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4386-91. PubMed ID: 6467199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accumulation of 3 H-estradiol in testes and pituitary glands of mice of strains differing in susceptibility to testicular interstitial cell and pituitary tumors after prolonged estrogen treatment.
    Bollengier WE; Eisenfeld AJ; Gardner WU
    J Natl Cancer Inst; 1972 Sep; 49(3):847-52. PubMed ID: 4647498
    [No Abstract]   [Full Text] [Related]  

  • 11. Interactions of putative estrogens with the intracellular receptor complex in mouse Leydig cells: relationship to preneoplastic hyperplasia.
    Juriansz RL; Huseby RA; Wilcox RB
    Cancer Res; 1988 Jan; 48(1):14-8. PubMed ID: 3334987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leydig cell tumor in patient on estrogen therapy.
    Deshmukh AS; Hartung WH
    Urology; 1983 May; 21(5):538-9. PubMed ID: 6857903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of a direct carcinogenic effect of estradiol on Leydig cells of the mouse.
    Huseby RA
    Cancer Res; 1980 Apr; 40(4):1006-13. PubMed ID: 7357531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-specific mechanism in rat Leydig cell tumorigenesis by procymidone.
    Murakami M; Hosokawa S; Yamada T; Harakawa M; Ito M; Koyama Y; Kimura J; Yoshitake A; Yamada H
    Toxicol Appl Pharmacol; 1995 Apr; 131(2):244-52. PubMed ID: 7716766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent lack of immunogenicity of estrogen-induced testicular Leydig cell tumors in BALB/c mice.
    Huseby RA; Page RH
    Cancer Res; 1982 Nov; 42(11):4332-8. PubMed ID: 6751521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in fine structure accompanying estrogen-induced tumorigenesis of Leydig cells in the mouse testis.
    Kurland G; Christensen AK; Huseby RA
    Cancer Res; 1975 Jul; 35(7):1671-86. PubMed ID: 236824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presence of two types of estrogen binding sites in mouse testis.
    Terakawa N; Aono T; Matsumoto K
    J Steroid Biochem; 1985 Jan; 22(1):147-50. PubMed ID: 3974225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testicular Leydig cell tumourigenesis by diethylstilbestrol in the BALB/c mouse. Histologic and histochemical study.
    Baroni C; Magrini U; Martinazzi M; Bertoli G
    Eur J Cancer (1965); 1966 Aug; 2(3):211-20. PubMed ID: 5974757
    [No Abstract]   [Full Text] [Related]  

  • 19. Biological and biochemical characterization of estrogen-dependent mouse Leydig cell tumors.
    Sato B; Miyashita Y; Nishizawa Y; Noma K; Kishimoto S; Mori H; Matsumoto K
    J Steroid Biochem; 1987; 27(1-3):421-9. PubMed ID: 3695489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biphasic stimulation of proliferation of Leydig cells by estrogen exposure.
    Du Mond JW; Singh KP; Roy D
    Int J Oncol; 2001 Mar; 18(3):623-8. PubMed ID: 11179496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.